Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01479517 · ClinicalTrials.gov registry record · Phase 2
Open-Label Study of Efficacy and Recommended Dose of Kovacaine Mist for Anesthetizing Maxillary Teeth
A Phase 2 study, sponsored by St. Renatus.
- Completed
- Registry status
- Phase 2
- Development phase
- 30
- Enrollment target
NCT01479517: Completed Phase 2 study, sponsored by St. Renatus.
NCT01479517 is a Phase 2 study that has completed, run by St. Renatus. The registered enrollment target is 30 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (77% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01479517, a Phase 2 study, has completed, sponsored by St. Renatus.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the efficacy of and recommended dosing regimen for unilateral administration of Kovacaine Mist in inducing pulpal anesthesia of the maxillary teeth for dental procedures.
Interventions
- DRUG Kovacaine Mist 0.1 mL x 4 sprays
- DRUG Kovacaine Mist 0.2 mL x 2 sprays
- DRUG Kovacaine Mist 0.2 mL x 1 spray
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2012-01 |
| Est. Completion | 2012-04 |
| Phase | Phase 2 |
What the finished NCT01479517 record still lists
NCT01479517 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (77% lower).
The record links to 0 conditions, and to 3 interventions - of which Kovacaine Mist 0.1 mL x 4 sprays is the first listed.
NCT01479517 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01479517 about?
NCT01479517 is a clinical study titled "Open-Label Study of Efficacy and Recommended Dose of Kovacaine Mist for Anesthetizing Maxillary Teeth". The purpose of this study is to evaluate the efficacy of and recommended dosing regimen for unilateral administration of Kovacaine Mist in inducing pulpal anesthesia of the maxillary teeth for dental procedures.
What is the current status of trial NCT01479517?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2012-01. Estimated completion is 2012-04.
What interventions are being tested in trial NCT01479517?
The interventions under investigation include: Kovacaine Mist 0.1 mL x 4 sprays (DRUG), Kovacaine Mist 0.2 mL x 2 sprays (DRUG), Kovacaine Mist 0.2 mL x 1 spray (DRUG).
Who is sponsoring clinical trial NCT01479517?
This trial is sponsored by St. Renatus, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01479517's enrollment target sits among peer trials
30 1582nd of 2000 higher than 332 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia